Nadia Whittley

Nadia Whittley serves as Chief Executive Officer at Verso Biosense, a leading UK FemTech company that offers a novel battery-free uterine monitoring platform designed to enhance women's health through continuous real-time data monitoring. In addition to their executive role, Nadia holds board positions at Less Grey Imaging and Presymptom Health, and provides advisory support to Ersel. Previously, Nadia was Chair and Board Member at Italia In Campus, and served as a Professional Associate at TEFEN & PARTNERS LIMITED, as well as Chief Executive Officer at Arquer Diagnostics, a company specializing in non-invasive diagnostic tests for bladder and prostate cancer. Additional experience includes serving as Partner & Managing Director Europe at Tefen and Board Director at Peptonic Medical.